JPIAMR invited selected scientific experts of antimicrobial resistance and representatives of national funding agencies to participate in a brainstorming workshop in Brussels October 9th and 10th. The objective was to provide a list of potential joint activities that could be included in the roadmap for implementation of the JPIAMR Strategic Research Agenda (SRA). Two independent groups of experts and funders discussed different subtopics of the six priorities Therapeutics, Diagnostics, Surveillance, Transmission, Environment and Intervention with the aim to generate suggestions for prioritized actions and instruments. The two groups agreed on a shortlist of themes for future calls and other actions that will be presented to the JPIAMR Management Board for future decisions.
Category: News and press
The new Research Commissioner, Carlos Moedas, questioned about AMR research in Europe, click here for the hearing
3rd International One Health Congress, 15-18 2015, The Netherlands
The 3rd International One Health Congress brings science and policy together aiming at the early recognition and control of emerging (infectious) diseases, now and in the years to come.
CONGRESS THEME: PREVENTION AT THE SOURCE
Prevention at the source is key in controlling (infectious) diseases that have a growing impact on humans, animals and their ecosystems.
15-18 March 2015 | Amsterdam | The Netherlands
For more information click here
JPIAMR active participant to the World Health Organization
JPIAMR has actively participated to the World Health Organization (WHO) consultation sent this summer to relevant organisations. The invitation was in order to contribute to their global action plan to combat antimicrobial resistance, which should be submitted to their sixty-eighth World Health Assembly in May 2015.
EC launch in 2015 of Prize on Diagnostics: “Reducing the Mis-use of Antibiotics Prize”
The EC will launch in 2015 a new €1 million prize on Diagnostics: “Reducing the Mis-use of Antibiotics Prize”. This Prize will reward a rapid test that can identify at the point of care patients with upper respiratory tract infections that can be managed safely without antibiotics.
http://europa.eu/rapid/press-release_MEMO-14-492_en.htm
Simultaneously, the UK has announced a £10 million prize “The Longitude Prize 2014” for Antibiotics which will be launched 6 October 2014. The EC Horizon 2020 prize and the UK Longitude Prize are two different but complementary initiatives.
http://www.longitudeprize.org/
JPIAMR seek ways of cooperation with the Mediterranean area, read more
JPIAMR took part last 15 July in Bari (Italy) on the Inter-Institutional Meeting JPIs-MPCs. The meeting seek ways of cooperation between JPIs and the Mediterranean area. Mainly through the enhancement of research and innovation in the Euro-Mediterranean region by fostering dialogue between policy makers and coordinators or representatives of different Joint Programming Initiatives (JPIs) that involve or could involve Mediterranean Partner Countries (MPCs).
Click here to download notes from the MPCs-JPI meeting 
Call for Gram negative anti-bacterial hit/lead programmes, deadline September 9, click here for more information
Antibiotic and their Alternatives. Fixing and feeding the Pipeline. Joint Workshop JPIAMR-EC-IMI-EPFIA
FDA progress report on Antimicrobial Resistance strategy
Heads of International Biomedical Research Organisations (HIROs) meeting in Shanghai on July 2.
Mats Ulfendahl, Chair of JPIAMR, lead the discussion on “International priorities surrounding antimicrobial resistance and development of new antibiotics”.
